Ganesh Raj,.doc

GANESH V. RAJ, M.D. Ph.D.UT Southwestern Medical Center

5323 Harry Hines Blvd., J8.130, Dallas, TX [email protected]

office: 214-648-8532, fax:214-648-8786mobile: 646-241-2104

FACULTY APPOINTMENTS ASSISTANT PROFESSOR (CLINICAL SCHOLAR TRACK)

DEPARTMENT OF UROLOGY UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, DALLAS, TX (2006- )

CHIEF GU ONCOLOGY

DEPARTMENT OF UROLOGY PARKLAND HOSPITAL, DALLAS, TX (2008- )

HOSPITAL AND ADMINISTRATIVE APPOINTMENTS 2006- present ATTENDING SURGEON

Hospitals of the University of Texas Southwestern Medical Center Dallas, Texas

2006- present ATTENDING SURGEON

2008- present CHIEF, GU ONCOLOGYParkland HospitalDallas, Texas

2006- present ATTENDING SURGEON North Texas Veterans Affairs Medical CenterDallas, Texas

EDUCATION AND TRAINING FELLOWSHIP IN UROLOGIC ONCOLOGY

MEMORIAL SLOAN KETTERING CANCER CENTER, NEW YORK, NY. (2004-2006)

RESIDENCY PROGRAM IN UROLOGY

RESEARCH FELLOWSHIP IN NEUROUROLOGYDUKE UNIVERSITY MEDICAL CENTER, DURHAM, NC. (1997-2004)

DOCTOR OF MEDICINE DOCTOR OF PHILOSOPHY (GENETICS)

Gibbons Scholars M.D./Ph.D. ProgramDissertation: Molecular pathogenesis of JC virus induced demyelination and tumorsThesis Advisor: Professor Kamel Khalili, Ph.D.JEFFERSON MEDICAL COLLEGE, PHILADELPHIA, PA. (1990-1997)

BACHELOR OF ARTS (BIOLOGY) WITH HONORSJOHNS HOPKINS UNIVERSITY, BALTIMORE, MD. (1986-1990)

GANESH V. RAJ, M.D. Ph.D. PAGE 2 OF 23

HONORS AND AWARDS ASCO FOUNDATION MERIT AWARD

Awarded to the top-rated abstract in genitourinary oncology Genitourinary Cancer Symposium, San Francisco, CA (2008)

BEST POSTER IN SESSION – UPPER TRACT UROTHELIAL TUMORSAUA annual meeting, San Francisco, CA (2007)

ASCO FOUNDATION MERIT AWARD Awarded to the top-rated abstract in prostate cancer Prostate Cancer Symposium, San Francisco, CA (2006)

SOCIETY OF MEMORIAL SLOAN KETTERING RESEARCH AWARDAwarded for perineural therapeutics and cavernous nerve injury Society of Memorial Sloan Kettering (2005)

AUA/UROLOGY RESIDENTS AND FELLOWS FORUM OF EXCELLENCETRAVEL FELLOWSHIP/ FINALIST, Excellence in urologic clinical research.AUA annual meeting, San Francisco, CA (2004)

AUA/PRAECIS GERALD P. MURPHY SCHOLARDistinction in the study of prostate cancer.AUA annual meeting, Orlando, FL (2002)

NORTH CAROLINA UROLOGY RESIDENTS SEMINAR (2ND PLACE)Excellence in urologic clinical case presentation.NC urology annual symposium, Grandover, NC (2002)

MONTAGUE BOYD ESSAY CONTEST (2ND PLACE)Excellence in research in urology. SESAUA annual meeting, Naples, FL (2002)

AUA CIRCON BASIC SCIENCE RESEARCH AWARD (1ST PLACE)Basic science research in urology. AUA annual meeting, Anaheim, CA (2001)

AUA RESEARCH CONFERENCE TRAVEL FELLOWSHIPInvitation-only AUA research conference.Molecular Approaches to Therapy in Urologic Diseases, Houston, TX (2001)

WECK CLOSURE SYSTEMS AWARD (3RD PLACE)Excellence in basic science research.Department of Surgery, Duke University Medical Center, Durham, NC (2001)

NATIONAL KIDNEY FOUNDATION OF NORTH CAROLINA RESEARCH AWARDAwarded for molecular analyses of renal cancer by cDNA microarrays.National Kidney Foundation, Raleigh NC (2000-2001)

PAUL D. ZIMSKIND MEMORIAL PRIZE IN UROLOGYAcademic excellence in urology.Jefferson Medical College, Philadelphia, PA (1997)


HONORS AND AWARDS (continued)

HYMAN MENDUKE RESEARCH PRIZEExcellence in research. Jefferson Medical College, Philadelphia, PA (1997)

SIGMA XI RESEARCH AWARD (1ST PLACE)Most outstanding basic science research of the year. Philadelphia Chapter, Sigma Xi Research Society, Philadelphia, PA (1994)

GIBBONS SCHOLARS M.D./PH.D. SCHOLARSHIPFully funded scholarship for graduate training.Thomas Jefferson University, Philadelphia, PA (1990-1997)

RESEARCH GRANTS

PRIMARY INVESTIGATOR

Prostate Cancer Foundation New Investigator Award (2008-2011)Role of cancer cell migration in the metastasis of prostate cancer to boneTotal: $225,000$75,000/year for 3 yearsMentor: JT Hsieh

Society of Memorial Sloan Kettering (2005)Application of perineural therapeutics to cavernous nerve injury. $85,000/1 yearCo-investigator: John Mulhall, MD

National Kidney Foundation of North Carolina (2000)Molecular analyses of renal cell carcinomas by cDNA microarrays.$10,000/1 yearCo-investigator: Thomas Polascik, MD.

The Dorothy and James Cleo Thompson, Jr. Fund (2008)for Research and Clinical Projects in Bladder Cancer$50,000/ 18 monthsPI: Ganesh V. Raj

North and Central Texas Clinical and Translational Science Initiative (NCTCTSI) Pilot Grant Award Program (2008)Evaluation of prostate cancer cell migration using a novel microfluidic model$48,664/ 12 monthsPI: Ganesh V. Raj


INVITED SPEAKERAOA Grand Rounds, Jefferson Medical College, Philadelphia, PA

(1997)“JC virus and PML”

13th Annual Paul Peters Symposium, Dallas TX (2007)“Preoperative Non-invasive evaluation of the histologies of renal

masses” “Salvage Therapies for recurrent Disease”Panel discussant: Partial Nephrectomy v AblationMultimodality panel organizer for prostate, Kidney and Bladder cancer

Texas Urologic Society Annual Meeting, Galveston, TX (2007)Testes Cancer

14th Annual Paul Peters Symposium, Dallas TX (2008)“Management of patients with rising PSA” Panel discussant: Bladder CancerMultimodality panel organizer for prostate, Kidney and Bladder cancerBreakout Session Chair: Focal ablative therapies in Urologic Oncology

Understanding Bladder Cancer - BCAN Patient Forum, Dallas TX (2008)

Surgical Management of Invasive Bladder CancerCurrent Initiatives in Bladder Cancer Research

15th Annual Paul Peters Symposium, Dallas TX (2009)“Management of patients with rising PSA” Panel discussant: role of lymphadenectomy in bladder cancerMultimodality panel organizer for prostate, Kidney and Bladder cancer

COURSE DIRECTOR14th Annual Paul Peters Symposium, Dallas TX (2008)Co-Director with Dr. Phillippe Zimmern

15th Annual Paul Peters Symposium, Dallas TX (2009)Co-Director with Dr. Phillippe Zimmern

INVITED MODERATOR

PROSTATE CANCER AUA South Central Annual Meeting, San Diego, CA (2008)


INVESTIGATOR INITIATED CLINICAL TRIALS:PI: EVEROLIMUS FOR METASTATIC TCC IN PATIENTS WHO HAVE RECEIVED PRIOR PLATINUM-BASED CHEMOTHERAPY OR ARE INELIGIBLE FOR CISPLATINUM-BASED CHEMOTHERAPY WITH CORRELATIVE TUMOR STUDIES: UTSOUTHWESTERN MEDICAL CENTER, DALLAS TX

SPONSOR: NOVARTIS

PI: PROSPECTIVE EVALUATION OF THE UTILITY OF 3T ENDORECTAL COIL MRI TO PREOPERATIVELY TO LOCALIZE CANCER IN PATIENTS WITH PROSTATE CANCER PRIOR TO SURGICAL INTERVENTION. UTSOUTHWESTERN MEDICAL CENTER, DALLAS TX SPONSOR: MEDRAD

PI: ACTIVE SURVEILLANCE FOR PATIENTS WITH PROSTATE CANCER. UTSOUTHWESTERN MEDICAL CENTER, DALLAS TX

PI: PROSPECTIVE EVALUATION OF THE UTILITY OF 3T ENDORECTAL COIL MRI TO LOCALIZE CANCER IN PATIENTS UNDERGOING A REPEAT PROSTATE BIOPSY FOR CAUSE AFTER A PRIOR NEGATIVE BIOPSY

UTSOUTHWESTERN MEDICAL CENTER, DALLAS TX

SPONSOR: MEDRAD

CLINICAL TRIALS:SITE CO-PI WITH DR. JOHNATHAN DOWELL

CSP-553: CHEMOTHERAPY AFTER PROSTATECTOMY FOR HIGH RISK PROSTATE CARCINOMA: A PHASE III RANDOMIZED STUDY

FUNDING: CSP-553 (1/1/08-5/2015)VA MEDICAL CENTER, DALLAS TX (2008- )Effort: 5%

SITE PI: GENITOURINARY RESEARCH NETWORK, STUDY 08-CT-001:PHASE III MULTIINSTITUTIONAL RANDOMIZED CLINICAL TRIAL: EFFECT OF TYPE OF ISCHEMIA – WARM VS. COLD DURING PARTIAL NEHRECTOMY ON RENAL FUNCTION

FUNDING: NONE

UTSOUTHWESTERN MEDICAL CENTER, DALLAS TXEffort: 2%

CO-PI: NEOADJUVANT EVEROLIMUS FOR ADVANCED RCC BEFORE CYTOREDUCTIVE NEPHRECTOMY, WITH CORRELATIVE TUMOR STUDIES: FUNDING: NOVARTIS

VA MEDICAL CENTER, DALLAS TXUTSOUTHWESTERN MEDICAL CENTER, DALLAS TXEffort: 2%


PEER REVIEWED SCIENTIFIC ARTICLES

1. Taylor JP, Pomerantz RJ, Raj GV, Kashanchi F, Brady JN, Amini S, Khalili K. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. J Virol 68(6):3971-3981, 1994.

2. Kerr D, Chang CF, Chen N, Gallia G, Raj G, Schwartz B, Khalili K. Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68(11):7637-7643, 1994.

3. Raj GV, Khalili K. Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol 14(12):7770-7781, 1994.

4. Raj GV, Gordon J, Logan TJ, Giordano A, Hall DJ, Khalili K. Characterization of glioma cells derived from human polyomavirus-induced tumors in hamsters. Int J Oncology 7-801-808, 1995.

5. Raj GV, Khalili K. Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213(2):283-91, 1995.

6. Raj GV, Ansari SA, Khalili K. Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV. Oncogene 12(6):1279-88, 1996.

7. Raj GV, Cupp C, Khalili K, Kim SJ, Amini S. Soluble factors secreted by activated T-lymphocytes modulate the transcription of the immunosuppressive cytokine TGF-beta 2 in glial cells. J Cell Biochem 62(3):342-55, 1996.

8. Raj GV, Safak M, MacDonald GH, Khalili K. Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1. J Virol 70(9):5944-53, 1996.

9. Thatikunta P, Raj GV, Kundu M, Khalili K, Amini S. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells. Oncogene 14(24):2959-69, 1997.

10. Gomella LG, Raj GV, Moreno JG. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol 158(2):326-37, 1997.

11. Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82(8):1419-42, 1998.

12. Raj GV, Gallia GL, Chang CF, Khalili K. T-antigen-dependent transcriptional initiation and its role in the regulation of human neurotropic JC virus late gene expression. J Gen Virol 79(9):2147-55, 1998.

13. Raj GV, Bennett RT, Preminger GM, King LR, Wiener JS. The incidence of nephrolithiasis in patients with spinal dysraphism. J Urol 162(3):1238-1242, 1999.


14. Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 85(1):249-250, 1999.

PEER REVIEWED SCIENTIFIC ARTICLES (CONTINUED)

15. Raj GV, Pruitt SK, Lilly S, Madden JT, Price DT. Multimodality therapy for adult Wilms Tumor Stage IV. J Urol 165:1202, 2001.

16. Reddan D, Raj GV, Polascik TJ. Management of small renal tumors. Am J Med 110:558-562, 2001.

17. Raj GV, Barki-Harrington L, Kue, PF, Daaka Y. Guanosine phosphate binding protein coupled receptors in prostate cancer. J Urol 167:1458-63, 2002.

18. Raj GV, Partin AW, Polascik TJ. Utility of 111In-Capromab pendetide immunoscintigraphy in the detection of early recurrent disease after radical prostatectomy. Cancer 94:987-96, 2002.

19. Lallas CD, Auge BK, Raj GV, Santa-Cruz R, Preminger GM. Access sheath is associated with no significant changes in ureteral blood flow as measured by Doppler ultrasound. J. Endourology 16(8):583-591, 2002.

20. Raj GV, Reddan D, Hoey MB, Polascik TJ. Management of small renal tumors with radiofrequency ablation. Urology 61(1):23-29, 2003.

21. Raj GV, Madden JF, Anderson EE. Liposarcoma of the ureter presenting as an obstructing intraluminal mass. Urology 61(5):1035, 2003.

22. Raj GV, Ellington KS, Polascik TJ. Autoimmune Testicular vasculitis. Urology 61(5):1035, 2003.

23. Raj GV, Auge B, Weizer A, Denstedt J, Watterson J, Beiko D, Assimos D, Preminger GM. Percutaneous management of calculi within horseshoe kidneys. J Urol 170: 48-51, 2003.

24. Weizer AZ, Silverstein AD, Auge BK, Delvecchio FC, Raj GV, Albala DM, Leder RM, Preminger GM. Determing the incidence of horseshoe kidneys from radiographic data at a single institution. J. Urol 170(5):1722-1726, 2003.

25. Auge BK, Pietrow, PK, Lallas CD, Raj GV, Santa-Cruz R, Preminger GM. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourology 18(2):157-161, 2004.

26. Raj GV, Auge B, Assimos D, Preminger GM. Metabolic abnormalities associated with calculi within horseshoe kidneys. J. Endourology 18(2):157-161, 2004.

27. Raj GV, Sekula J, Kim J, Madden JF, Daaka Y. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-

B. Prostate, 61:105-113, 2004.


28. Raj GV, Brashears JH, Anand A, Paulson DF, Polascik TJ. Does a prior negative prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Urology, 65:332-336, 2005.



29. Anger JT, Raj GV, Delvecchio FC, Webster GD. Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management. J Urology, 173: 1143-1146, 2005.

30. Raj GV, Peterson AC, Toh KL, Webster GD. Outcomes following revisions and secondary implantation of the artificial urinary sphincter. J Urology, 173: 1242-1245, 2005.

31. Brashears JH, Raj GV, Crisci A, Young MD, Dylewski D, Nelson RA, Madden JF, Polascik TJ. Renal cryo and radiofrequency ablation: worst-case scenarios in a porcine model. J Urology, 173:2160-2165, 2005.

32. Madden JF, Raj GV, Burchette JL, Daly JT, Tannenbaum M. Anterior rectal wall gastrointestinal stromal mass presenting clinically as prostatic mass. Urologic Oncology 23(4):268-272, 2005.

33. Weizer AZ, Raj GV, Nelson RA, Polascik TJ. Complications following percutaneous radiofrequency ablation of renal tumors. Urology, 66: 1176-1180, 2005.

34. Raj GV, Bochner BH, Vickers A, Teper E, Lin O, Donat SM, Herr H, Dalbagni G. Association between urinary cytology and pathology for non-transitional cell malignancies of the urinary tract. J Urology, 175:2038-2041, 2006.

35. Raj GV, Peterson AC, Anger JT, Webster GD. Outcomes following erosions of the artificial urinary sphincter. J Urology, 175:2186-2190, 2006.

36. Raj GV, Iasonos A, Herr HW, Donat SM. Formulas estimating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. J Clinical Oncology, 24(19):3095-100, 2006.

37. Huang WC, Levey AS, Serio AM, Vickers A, Raj GV, Scardino PT, Russo P. Chronic kidney disease after nephrectomy in Patients with Renal Cortical Tumors: a retrospective cohort study. Lancet Oncology, 7:735-740, 2006.

38. Raj GV, Tal R, Vickers A, Bochner BH, Serio A, Donat SM, Herr H, Olgac S, Dalbagni G. Significance of intraoperative ureteral evaluation at Radical cystectomy for urothelial cancer. Cancer, 107 (9):2167-2172, 2006

39. Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G. Natural history of positive urinary cytology after radical cystectomy. J Urology, 176:2000-2005, 2006.

40. Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses < 7cm in radiologic diameter: Influence of sex. J Urology, 176: 2391-2396, 2006.

41. Raj GV, Bach A, Iasonos A, Korets R, Blitstein J, Hann L, Russo P. Utility of Pre-Operative Color Doppler Ultrasonography in Predicting the Histology of Renal Lesions. J Urology, 177: 53-58, 2007.



42. Raj GV, Yowell C, Madden JF, Nosnik IP, Mouraviev V, Polascik TJ. Malignant cystic nephroma. Can J Urology, 13(6): 3348-3350, 2006.

43. Secin FP, Koppie T, Salamanca JI, Bokhari S, Raj GV, Olgac S, Serio A, Vickers A, Bochner B. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int J Urology 14(1): 26-32, 2007.

44. Raj GV, Herr H, Serio A, Donat SM, Bochner B, Vickers AJ, Dalbagni G. Treatment paradigm shift improves survival of patients with superficial bladder cancer. J Urology, 177: 1283-1286, 2007.

45. Raj GV, Bochner B. Radical cystectomy and lymphadenectomy for invasive bladder cancer: Towards the evolution of an optimal surgical standard. Seminars in Oncology, 34(2):110-21, 2007

46. Marguet C, Raj GV, Brashears JH, Anscher MA, Ludwig KA, Mouraviev V, Robertson CN, Polascik TJ. Recto-urethral fistulae after combination radiotherapy for prostate cancer. Urology, 69:898-901, 2007.

47. Chen SH, Mouraviev V, Raj GV, Marguet CG, Polascik TJ. Ureteropelvic Junction Obliteration Resulting in Nephrectomy Following Radiofrequency Ablation of a Small Renal Cell Carcinoma. Urology, 69:982.e3-5, 2007.

48. Lucas SM, Stern JM, Adibi M, Zeltser IS, Caddedu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urology, 179: 75-80, 2008.

49. Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM. Longitudinal Risk of Upper Tract Recurrence Following Radical Cystectomy for Urothelial Cancer and Its Potential Implications for Long-term Surveillance. J Urology, 179: 96-100, 2008.

50. Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewica PI, Raj GV, Scheonberg MP, Lerner SP, Sagalowsky AI Shariat SF. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology, 71(2):302-7, 2008.

51. Iasonos A, Schrag D, Raj GV, Panageas. User’s guide to building and understanding nomograms. Journal of Clinical Oncology. 26(8):1364-70, 2008

52. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan M. Preoperative nomogram predicting histology of renal lesions. J Urology, 179: 2146-2151, 2008.

53. Lucas SM, Nuss G, Stern J, Lotan Y, Sagalowsky AI, Cadeddu JA, and Raj GV. The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small, unilateral renal masses. Cancer 113(10):2681-6. 2008)


http://www.ncbi.nlm.nih.gov/pubmed/18853420?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum




54.Shabsigh A , Korets R, Vora KC, Brook CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology. Eur Urol. 55: 164–176. 2009

55. Secin FP, Touijer K, Karanikolas NT, Raj GV, Guillonneau B. Laparoscopic radical prostatectomy: lessons learned in surgical technique. European Urology (in press 2009).

56. Gupta A, Lotan Y, Ashfaq R, Roehrborn CG, Raj GV, Aragaki CC, Montorsi F, Shariat SF. Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients. Eur Urol. 55: 1124-1134. 2009

57. Stern JM, Gupta A , Raman JD, Cost N, Lucas S, Lotan Y, Raj GV, Cadeddu JA. Radiofrequency Ablation of Small Renal Cortical Tumors in Healthy Adults: Renal Function Preservation and Intermediate Oncologic Outcome. BJU International (in press 2009)

58. Karam JA, Raj GV. Growing Teratoma Syndrome. Urology (in press 2009)

59. Raman JD, Raj GV, Lucas SM. Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA. Renal function outcomes for tumors ina a solitary kidney managed by ablative or extirpative techniques. BJU (in press 2009)

NON-PEER REVIEWED EDITORIALS AND PUBLICATIONS

1. Gomella LG, Raj GV, Moreno JG. Reply to the Editor: Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol 159(5):1649-650, 1998.

2. Woodard J, Raj GV, Docimo SG, Khoury AE, Wolpert J. Discussion: The incidence of nephrolithiasis in patients with spinal dysraphism. J Urol 162(3):1242, 1999.

3. Raj GV, Subramanian SV, Polascik TJ. Advances in deep vein thrombosis prophylaxis. Contemp Urol 12(9): 56-68, 2000.

4. Raj GV, Wiener JS. Varicoceles in adolescents: when to observe? when to intervene? Contemporary Pediatrics, 21: 31-44, 2004.

5. Raj GV, Wiener JS. Management of varicoceles in adolescents. Contemp Urol, 16 (7): 23-33, 2004.

6. Raj GV, Eastham, J. Are different therapeutic options for stage T1-T2 prostate cancer really equivalent? AJUR, 2(10): 507-8, 2004.

7. Raj GV, Bochner, BH. Contemporary approach to the urethra in patients undergoing radical cystectomy for invasive bladder cancer. AJUR, 3(6): 279-284, 2005.

8. Raj GV, Eastham J. Complications of androgen deprivation therapy. Contemp Urol, 17(12): 8-14, 2005



http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Donat%20SM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Herr%20HW%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dalbagni%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Bochner%20BH%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Raj%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Savage%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Cronin%20AM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Brook%20CM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Vora%20KC%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Korets%20R%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Shabsigh%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus


9. Raj, GV. Editorial Comments. J Urol 179(2): , 2008

ARTICLES SUBMITTED

1. Raj GV, Eastham J, Touijer K, Scardino PT, Guillonneau, B. Analyses of Global Charges associated with Contemporary Laparoscopic and Radical Retropubic Prostatectomies. (Cancer)

2. Raj GV, Iyer R, Bianco FJ, Vickers A, Guillonneau B, Reuter VE, Fine SW, Scardino PT, Eastham J. Utility of resection of additional peri-prostatic tissue in patients undergoing radical prostatectomy. (J Urology)

3. Raj GV, Herr H, Serio AM, Reutter V, Karanikolas N, Vora K, Donat SM, Bochner BH, Vickers AJ, Dalbagni G. Utility of intravesical BCG for patients with primary T1 bladder cancers. (J Urology)

4. Thompson RH, Raj GV, Lohse CM, Frank I, Zincke H, Russo P, Blute ML, and Leibovich BC. Preoperative and intraoperative features associated with positive lymph nodes during nephrectomy for renal cell carcinoma (J Urology)

5. Rao SMN, Raj GV, Lin VK, Hsieh JT, Nguyen, Chiao JC. Initial characterization of a novel Microfluidic Device to Evaluate Cancer Cell Migration. (Cell Motility)

6. Raj GV, Sagalowsky A. State of the Art: Optimizing Multimodality therapy for Patients with Muscle-invasive Bladder Cancer. (Recent Reviews in Clinical Trials)

7. Raj GV, Sagalowsky A. Current Clinical Trials in Urothelial Cancer (Recent Reviews in Clinical Trials)

8. Lucas SM, Dhanawala Z, Kattan M, Raj GV. Impact of Gleason grade upgrading on predicted outcomes of patients undergoing radical prostatectomy. (Cancer)

9. Karam JA, Raj GV. Effect of Sunitinib on IVC tumor thrombus. (JCO)

10. Decker DA, Raj GV. Giant hemangiopericytoma. (Urology)

11. Karavadia SS, Ho R, Arriaga Y, Sagolowsky, A, Lotan Y, Raj GV.Contemporary utilization of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. (Cancer)

12. Schlomer B, Ho R, Arriaga Y, Sagolowsky, A, Lotan Y, Raj GV. Should patients with muscle-invasive bladder cancer and concurrent hydronephrosis be treated with neoadjuvant chemotherapy? (Cancer)

13. Lucas SM, Raman JD, Tracy C, Bagrodia A, Donnally C, Cadeddu JA, and Raj GV. Laparoscopic versus Open Partial Nephrectomy: A Comparison of Renal Function Outcomes in patients with low and high SCORED values. (Cancer)


BOOK CHAPTERS

1. Clinician’s Pocket Reference. 8th edition. (1997).Bedside procedures Raj GV Gomella LG, Editor Appleton and Lange, Stamford, CT

2. Five Minute Urology Consult. 1st edition. (2000).Ureteroceles Raj GV, Wiener JSGomella LG, EditorLippincott, Williams and Wilkins, Philadelphia, PA

3. Surgery on Call. 3rd edition. (2001).Bedside proceduresRaj GV, Weidner BLefor AT, Gomella LG, EditorsLange Medical Books/ McGraw-Hill, New York, NY

4. Clinician’s Pocket Reference. 9th edition. (2002).Bedside ProceduresRaj GV, Weidner BGomella LG, EditorLange Medical Books/ McGraw-Hill, New York, NY

5. e-Medicine Radiology. 1st edition. (2002).UreterocelesRaj GV, Leder RS, Wiener J.S.Plantz SH, Editor. e-Medicine.com, St. Petersburg, FL

6. Handbook of Drug Allergy and Other Adverse Drug Reactions. 1st edition. (2004).Drug Allergy By Drug Class: Urology. Raj GV, Jones KS, Donatucci CF.Honsinger RW, Green GR, Editors. Lippincott Williams and Wilkins, Baltimore MD

7. Basic and Advanced Techniques in Prostate Brachytherapy 1st edition. (2005) p 43-57Prostate cancer staging: PSMA-based serum assays and radioscintigraphy. Raj GV, Polascik TJDicker A, Merrick G, Waterman F, Valicenti R, Gomella L. EditorsMartin Dunitz, London.

8. Bladder Cancer: Moving the Field Forward. 1st edition. (2007, in press)Beyond BCG: GemcitabineRaj GV, Dalbagni GLee CT and Wood DPEditors. Humana Press, Totowa NJ


ABSTRACTS PUBLISHED

1. Raj GV, Bennett RT, Preminger GM, King LR, Wiener JS. The incidence of nephrolithiasis in patients with spinal dysraphism. Pediatrics 102(3):877-8, 1998.

2. Raj GV, Partin AW, Polascik TJ. Utility of 111In-Capromab pendetide immunoscintigraphy in the detection of early recurrent disease after radical prostatectomy. J Urology 165(5):56, 2001.

3. Raj GV, Sekula J, Barki-Harrington L, Kim J, Kue P, Daaka, Y. Role of NF-B activation in LPA-mediated anti-apoptosis in hormone-independent prostate cancer cells, PC-3. J Urology 165(5):239, 2001.

4. Lallas CD, Auge B, Raj GV, Santa-Cruz R, Preminger GM. Access sheath is associated with no significant changes in ureteral blood flow as measured by Doppler ultrasound. J Urology 2002.

5. Raj GV, Auge B, Weizer A, Denstedt J, Watterson J, Beiko D, Assimos D, Preminger GM. Percutaneous management of calculi within horseshoe kidneys. J. Urol. 169(4):25, 2003.

6. Raj GV, Daaka, Y. Evidence for a novel survival pathway in androgen-independent prostate cancer. J Urology 169(4):87, 2003.

7. Raj GV, Peterson AC, Toh KL, and Webster GD. Outcomes following revisions and secondary implantation of the artificial urinary sphincter in cases of device malfunction, urethral atrophy and erosion. J Urology 169(4):121-122, 2003.

8. O’Connell MJ, Nelson RC, Brashears J, Raj GV and Roberston CN. Complications following percutaneous radiofrequency ablation of renal tumors. Am J Roentgenology 180(3):64, 2003.

9. Raj GV, Peterson AC, Anger JT, and Webster GD. Outcomes following erosions of the artificial urinary sphincter. J Urology 169(4):121-122, 2004.

10. L'Esperance JO, Springhart WP, Ekeruo WE, Raj GV, Albala DM, Preminger GM. Ureteroscopic management of symptomatic renal calculi: do ureteral access sheaths improve stone free rates? J Urology 169(4):121-122, 2004.

11. Brashears JH, Raj GV, Nelson RA, and Polascik TJ. Renal radiofrequency: worst-case scenarios in a porcine model. Am J Roentgenology 182(3):64, 2004.

12. Thomas J, Ho L, Raj GV, Leder RA, Webster GD. Imaging of the artificial urethral sphincter- appearance and complications. Am J Radiology (2004).

13. Weizer AZ, Raj GV, Nelson RA, and Polascik TJ. Complications following Percutaneous Radiofrequency Ablation of Renal Tumors. J Urology 173(4):26, 2005.

14. Sherman ND, Eldaif B, Raj GV, and Webster GD. Incontinence following treatment for prostate cancer: Does radiation therapy compromise outcomes of the Artificial Urinary Sphincter? J Urology 173(4):86-87, 2005.

15. Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Renal radiofrequency and cryo ablation: worst-case scenarios in a porcine model. J Urology 173(4):229, 2005.


16. Teper E, Raj GV, Bochner BH, Donat SM, Herr H and Dalbagni G. Predictive utility of urinary cytologies for non-urothelial malignancies of the urinary tract. J Urology 173(4):230, 2005.


ABSTRACTS PUBLISHED (CONTINUED)

17. Secin FP, Koppie T, Olgac S, Raj GV, Dalbagni G, and Bochner B. Clinical and pathological predictors of pathologic lymph node metastasis identified during nephroureterectomy for transitional cell carcinoma of the upper urinary tract. J Urology 173(4):264, 2005.

18. Raj GV, Bochner BH, Donat SM, Herr H and Dalbagni G. Natural history and clinical importance of patients with positive urinary cytologies after a radical cystectomy for transitional cell carcinoma. J Urology 173(4):375, 2005.

19. Raj GV, D. Cohen, H. B. Grossman, H. Herr, S. M. Donat, Bladder Cooperative Group. Impact of Body Mass Index on Quality of Surgery and Survival Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: a Cooperative Group Report. J Clin Oncology, 23: 4696, 2005.

20. Raj GV, Iasonos A, Herr HW, Donat SM. Formulas estimating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. J Urology 175(4):405, 2006.

21. Raj GV, Tal R, Bochner BH, Donat SM, Herr H, Dalbagni G. Significance of ureteral margin assessment at Radical cystectomy for bladder cancer. J Urology 175(4):404, 2006.

22. Raj GV, Iyer R, Bianco FJ, Vickers A, Guillonneau B, Reuter VE, Fine SW, Scardino PT and Eastham J. Utility of resection of additional peri-prostatic tissue in patients undergoing radical prostatectomy. J Urology 175(4):217, 2006.

23. Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses < 7cm in radiologic diameter: Influence of gender. J Urology 175(4):29, 2006.

24. Huang WC, Snyder M, Raj GV, Serio A, Vickers A , Russo P. Patients undergoing radical nephrectomy for small renal cortical tumors are at increased risk for developing chronic renal insufficiency. J Urology 175(4):238, 2006.

25. Shabsigh A, Raj GV, Korets R, Dotan ZA, Vora KC, Bochner BH, Dalbagni G, Herr HW, Donat SM. The Incidence and Risk Factors of Post-Operative Complications in Female Patients Undergoing Radical Cystectomy. J Urology 175(4):400, 2006.

26. Shabsigh A, Raj GV, Korets R, Joudy F, Chan D, Bochner BH, Dalbagni G, Herr HW, Donat SM. Risk Factors for Development of Metastatic Disease and Death in Female Patients Undergoing Radical Cystectomy. J Urology 175(4):405, 2006.

27. Raj GV, Thompson, RH, Liebovich B, Blute M, Russo P, Kattan M. Pre-surgical nomogram predicting 12-year probability of metastatic recurrence following nephrectomy for renal masses. J Urology 175(4):405, 2007.

28. Tran W, Raj GV, Serio AM, Dalbagni G, Vickers Aj, Bochner BH, Herr H, Donat SM. Time Course of Upper Tract Recurrence Following Radical Cystectomy for Urothelial Cancer. J Urology 175(4):405, 2007.

29. Iasonos A, Schrag D, Raj GV, Panageas K. User’s guide to building and understanding nomograms. J Clin Oncology 25: 328s, 2007.



RESEARCH PRESENTATIONS

Sigma Xi. Philadelphia, PA (1994)- Raj GV, Chepenik LG, Khalili K. A novel rapidly inducible transcription factor regulates JC-virus gene expression.

MD/PhD Conference on Aging. Aspen, CO (1994)- Raj GV, Khalili K. Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines.

Molecular biology of Papovaviruses and Adenoviruses. Cold Spring Harbor, NY (1994)

- Raj GV, Khalili K. Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines.

Sigma Xi. Philadelphia, PA (1995)- Raj GV, Khalili K. Evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1. (Award winner)

American Academy of Pediatrics. San Francisco, CA (1998)- Raj GV, Bennett RT, Preminger GM, King LR, Wiener JS. The incidence of nephrolithiasis in patients with spinal dysraphism. Section on Pediatric Urology.

Duke Comprehensive Cancer Center. Durham, NC (2001) - Raj GV, Daaka Y. GPCR-induced anti-apoptotic effect in prostate cancer.

South Eastern Section AUA. New Orleans, LA (2001)- Raj GV, Dahm P, Polascik TJ. Utility of Capromab Pentide in imaging early recurrent disease after a radical prostatectomy.

AUA Annual meeting. Anaheim, CA (2001)- Raj GV, Sekula J, Barki-Harrington L, Kim J, Kue P, Daaka Y. Role of NF-B activation in LPA-mediated anti-apoptosis in hormone-independent prostate cancer cells, PC-3. (Award winner)

- Raj GV, Partin AW, Polascik TJ. Utility of Capromab Pentide in imaging early recurrent disease after a radical prostatectomy.

AUA Summer Research Conference. Houston, TX (2001)- Raj GV. G-protein coupled receptors in prostate cancer. AUA Summer Research Conference: Molecular Approaches to Therapy in Urologic Disease. (Travel Fellowship winner)

North Carolina Urology Symposium. Grandover, NC (2001)- Lallas CD, Auge B, Raj GV, Santa-Cruz R, Preminger GM. Access sheath is associated with no significant changes in ureteral blood flow as measured by Doppler ultrasound. (Award winner)

World Congress of EndoUrology. Bangkok, Thailand (2001)- Lallas CD, Auge B, Raj GV, Santa-Cruz R, Preminger GM. Access sheath is associated with no significant changes in ureteral blood flow as measured by Doppler ultrasound.


RESEARCH PRESENTATIONS (continued)

AACR Special Conference in Cancer Research: Naples, FL (2001)- Raj GV, Daaka Y. G-proteins in Prostate cancer. AACR Special Conference in Cancer Research: New Discoveries in Prostate Cancer Biology and Treatment.

South Eastern Section AUA. Naples, FL (2002)- Dahm P, Raj GV, Paulson DF. Long term outcome of patients undergoing radical perineal prostatectomy for prostate cancer.

- Raj GV, Daaka Y. From G-proteins to NF-B: a novel survival pathway in prostate cancer.

- Raj GV, Daaka Y. A novel survival pathway in prostate cancer. (Montague Boyd talk)(Award winner)

AUA annual meeting. Orlando, FL (2002)- Lallas CD, Auge BK, Raj GV, Santa-Cruz R, Preminger GM. Access sheath is associated with no significant changes in ureteral blood flow as measured by Doppler ultrasound.

World Congress of EndoUrology. Genoa, Italy (2002)- Raj GV, Auge BK, Weizer A, Denstedt J, Watterson J, Beiko D, Assimos D, Preminger GM. Percutaneous management of calculi within horseshoe kidneys.

- Raj GV, Auge BK, Assimos D, Preminger GM. Metabolic abnormalities associated with calculi within horseshoe kidneys.

- Auge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz R, Preminger GM. The ureteral access sheath provides protection against elevated intra-renal pressures generated during routine flexible ureteroscopic stone manipulation

- Weizer AZ, Silverstein AD,Delvecchio FC, Terranova S, Raj GV, Auge BK, Albala DM, Preminger GM. Determing the incidence of horseshoe kidneys from radiographic data at a single institution.

North Carolina Urology Symposium. Grandover, NC (2002) - Raj GV, Crisci A, and Murphy BC. Squamous cell carcinoma of the bulbar

urethra. (Award winner)

ANNUAL SUO MEETING; UROLOGIC ONCOLOGY. BETHESDA, MD (2002)- Raj GV, Brashears JH, Paulson DF, Polascik TJ. DOES A PRIOR NEGATIVE PROSTATE BIOPSY PREDICT OUTCOME FOR PATIENTS TREATED WITH RADICAL PERINEAL PROSTATECTOMY?

- Raj GV, Daaka Y. LYSOPHOSPHATIDIC ACID PROMOTES SURVIVAL OF ANDROGEN-INSENSITIVE PROSTATE CANCER PC3 CELLS VIA ACTIVATION OF NFB.

South Eastern Section AUA. Savannah, GA (2003)- Raj GV, Crisci A, and Murphy BC. Rare invasive squamous cell carcinoma of the bulbar urethra. Leon T. Howard Pyelogram hour.


- Auge BK, Pietrow, PK, Lallas CD, Raj GV, Santa-Cruz R, Preminger GM. The ureteral access sheath provides protection against elevated renal pressures generated during routine flexible ureteroscopic stone manipulation.

- Raj GV, Auge B, Weizer A, Denstedt J, Watterson J, Beiko D, Assimos D, Preminger GM. Percutaneous management of calculi within horseshoe kidneys.


AUA annual meeting. Chicago, IL (2003)- Raj GV, Daaka Y. A novel survival pathway in prostate cancer.

- Raj GV, Peterson AC, Toh KL, and Webster GD. Outcomes following secondary implant of the artificial urinary sphincter.

- Raj GV, Auge B, Weizer A, Denstedt J, Watterson J, Beiko D, Assimos D, Preminger GM. Percutaneous management of calculi within horseshoe kidneys. AUA annual meeting. Chicago, IL (2003).

American Roentgen Ray Society meeting, San Diego, CA (2003)- O’Connell MJ, Nelson RC, Brashears J, Raj GV and Roberston CN. Percutaneous radiofrequency ablation of renal tumors.

North Carolina Urology Symposium. Grandover, NC (2003)- Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Renal radiofrequency ablation: worst-case scenarios in a porcine model.

ANNUAL SUO MEETING; UROLOGIC ONCOLOGY. BETHESDA, MD (2003)- Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Renal radiofrequency and cryo ablation: worst-case scenarios in a porcine model.

European Association of Urology. Vienna, Austria (2004)- Crisci AC, Brashears JH, Raj GV, Nelson RA, and Polascik TJ. Renal radiofrequency: worst-case scenarios in a porcine model.

- Crisci AC, Brashears JH, Raj GV, Nelson RA, and Polascik TJ. Renal cryotherapy: worst-case scenarios in a porcine model.

South Eastern Section AUA. Aruba (2004)- Weizer AZ, Raj GV, Nelson RA, and Polascik TJ. Complications following percutaneous radiofrequency ablation of renal tumors.

- Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Renal radiofrequency: worst-case scenarios in a porcine model.

AUA annual meeting. San Francisco, CA (2004)- Raj GV, Peterson AC, Tash J, and Webster GD. Outcomes following erosions of the artificial urinary sphincter.

- L'Esperance JO, Springhart WP, Raj GV, Albala DM, Preminger GM. Ureteroscopic management of symptomatic renal calculi: do ureteral access sheaths improve stone free rates?

- Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Renal radiofrequency and cryo ablation: worst-case scenarios in a porcine model. Urology Residents and Fellows Forum of Excellence. (Award winner)

American Roentgen Rays Society annual meeting, Miami FL (2004)


- Brashears JH, Raj GV, Nelson RA, and Polascik TJ. Renal radiofrequency: worst-case scenarios in a porcine model.


RSNA annual meeting, Chicago, IL (2004)- Thomas J, Ho L, Raj GV, Leder RA, Webster GD. Imaging of the artificial urethral sphincter- appearance and complications.

Annual SUO Meeting; Urologic Oncology. Bethesda, MD (2004)- Weizer AZ, Raj GV, Nelson RA, and Polascik TJ. Complications following percutaneous radiofrequency ablation of renal tumors.

- Raj GV, Herr, HW and the Bladder Cooperative Group. Impact of lymph node density on bladder cancer survival outcomes: a cooperative group report.

South Eastern Section AUA. Charleston, SC (2005)- Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Intentional renal cryosurgical ablation of vital renal structures in a porcine model.

ASCO 2005 Multidisciplinary Prostate Cancer Symposium, Orlando, FL (2005)

- Raj GV, Brashears JH, Paulson DF, Polascik TJ. Does a prior negative prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?

AUA annual meeting. San Antonio, TX (2005)- Teper E, Raj GV, Bochner BH, Donat SM, Herr H and Dalbagni G. Predictive utility of urinary cytologies for non-urothelial malignancies of the urinary tract.

- Raj GV, Bochner BH, Donat SM, Herr H and Dalbagni G. Natural history and clinical importance of patients with positive urinary cytologies after a radical cystectomy for transitional cell carcinoma.

- Raj GV, Brashears JH, Nelson RA, and Polascik TJ. Renal radiofrequency and cryo ablation: worst-case scenarios in a porcine model.

- Secin FP, Koppie T, Olgac S, Raj GV, Dalbagni G, and Bochner B. Clinical and pathological predictors of pathologic lymph node metastasis identified during nephroureterectomy for transitional cell carcinoma of the upper urinary tract.

- Weizer AZ, Raj GV, Nelson RA, and Polascik TJ. Complications following Percutaneous Radiofrequency Ablation of Renal Tumors.

- Sherman ND, Eldaif B, Raj GV, and Webster GD. Incontinence following treatment for prostate cancer: Does radiation therapy compromise outcomes of the Artificial Urinary Sphincter?

ANNUAL SUO MEETING; UROLOGIC ONCOLOGY. BETHESDA, MD (2005)- Huang W, Snyder M, Serio A, Raj GV, Vickers A, Russo P. Patients undergoing radical nephrectomy for small renal cortical tumors are at risk for chronic renal insufficiency.

- Raj GV, Bach A, Iasonos A, Blitstein J, Hann L, and Russo P. Correlation of color doppler ultrasonography with histology of renal lesions.


- Koppie TM, Serio A, Vora K, Raj GV, Dalbagni G, Herr HW, and Bochner BH. Age-adjusted comorbidity is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.

- Sharp DS, Raj GV, Gopalan A, Olgac S and Herr H. Management of Patients with Solitary Lesions at the Bladder Dome with Wide Local Excision Partial Cystectomy


ASCO 2006 Multidisciplinary Prostate Cancer Symposium, San Francisco, CA (2006)

- Raj GV, Iyer R, Bianco FJ, Vickers A, Guillonneau B, Scardino PT, Reuter VE, Fine SW and Eastham J. Utility of resection of additional peri-prostatic tissue in patients undergoing radical prostatectomy? (Award winner)

AUA annual meeting. Atlanta, GA (2006)- Raj GV, Iasonos A, Herr HW, Donat SM. Formulas estimating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer.

- Raj GV, Tal R, Bochner BH, Donat SM, Herr H, Dalbagni G. Significance of ureteral margin assessment at Radical cystectomy for bladder cancer.

- Raj GV, Iyer R, Bianco FJ, Vickers A, Guillonneau B, Reuter VE, Fine SW, Scardino PT and Eastham J. Utility of resection of additional peri-prostatic tissue in patients undergoing radical prostatectomy.

- Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses < 7cm in radiologic diameter: Influence of gender.

- Huang WC, Snyder M, Raj GV, Serio A, Vickers A , Russo P. Patients undergoing radical nephrectomy for small renal cortical tumors are at increased risk for developing chronic renal insufficiency.

- Shabsigh A, Raj GV, Korets R, Dotan ZA, Vora KC, Bochner BH, Dalbagni G, Herr HW, Donat SM. The Incidence and Risk Factors of Post-Operative Complications in Female Patients Undergoing Radical Cystectomy

- Shabsigh A, Raj GV, Korets R, Joudy F, Chan D, Bochner BH, Dalbagni G, Herr HW, Donat SM. Risk Factors for Development of Metastatic Disease and Death in Female Patients Undergoing Radical Cystectomy.

ASCO annual meeting, Atlanta, GA (2006)- Raj GV, Bach A, Iasonos A, Korets R, Blitstein J, Hann L, Russo P. Utility of Pre-Operative Color Doppler Ultrasonography in Predicting the Histology of Renal Lesions.

ASA Joint Statistical Meeting, Seattle, WA (2006)- Iasonos A, Raj GV, Russo P. Predicting Malignant Renal Lesions by Using Pre-Operative Color Doppler Ultrasonography: Building a Nomogram.


ANNUAL SUO MEETING; UROLOGIC ONCOLOGY. BETHESDA, MD (2006)- Raj GV, Herr H, Dalbagni G. Treatment paradigm shift improves survival of

patients with superficial bladder cancer

AUA annual meeting. Anaheim, GA (2007)- Raj GV, Thompson, RH, Liebovich B, Blute M, Russo P, Kattan M. Pre-

surgical nomogram predicting 12-year probability of metastatic recurrence following nephrectomy for renal masses.


- Tran W, Raj GV, Serio AM, Dalbagni G, Vickers Aj, Bochner BH, Herr H, Donat SM. Time Course of Upper Tract Recurrence Following Radical Cystectomy for Urothelial Cancer. (Award winner)

ASCO annual meeting, Atlanta, GA (2007)- Iasonos A, Schrag D, Raj GV, Panegas. User’s guide to building and

understanding nomograms

UTMB Medical Student Presentations, Galveston, TX (2007)- Dhanawala Z, Lucas S, Raj GV. Impact of Gleason up-grading on altering

the predicted outcome based on the pre-operative nomogram.

South Central Section meeting, Colorado Springs, CO (2007)- Lucas SM, Stern JM, Adibi M, Zeltser IS, Caddedu JA, Raj GV. Renal

function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques.

- Gupta A, Lotan Y, Ashfaq R, Roehrborn CG, Raj GV, Shariat SF. Predictive value of the differential expression of the urokinase plasminogen activation axis in patients treated with radical prostatectomy.

- Gupta A, Lotan Y, Ashfaq R, Roehrborn CG, Raj GV, Shariat SF. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.

World Congress of Endourology, Cancun, Mexico (2007)- Lucas SM, Stern JM, Adibi M, Zeltser IS, Caddedu JA, Raj GV. Renal

function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques.

ANNUAL SUO MEETING; UROLOGIC ONCOLOGY. BETHESDA, MD (2007)- Lucas SM, Dhanawala Z, Raj GV. Minimal contribution of a change in

Gleason Score to the predicted outcomes of patients with prostate cancer.

- Raj GV, Lucas SM, Adibi M. The scored value predicts patients with small unilateral renal masses at risk for having or developing chronic kidney disease.

UT Southwestern Metroplex Day (2008)- Rao SMN, Rahimi M, Huggins C, Nguyen K, Chiao JC, Raj GV, Hsieh JT.

Microfluidic Devices to Investigate Prostate Cancer Cell Migration Toward Chemokine Gradients


ASCO Genitourinary Cancer Symposium, San Francisco, CA (2008)- Lucas SM, Dhanawala Z, Raj GV. Minimal contribution of a change in

Gleason Score to the predicted outcomes of patients with prostate cancer.

- Raj GV, Lucas SM, Adibi M. The scored value predicts patients with small unilateral renal masses at risk for having or developing chronic kidney disease. (Award winner)


- Lucas SM, Stern JM, Adibi M, Zeltser IS, Caddedu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques.

AUA annual meeting. Orlando, FL (2008)- Thompson, RH. Raj GV, Leibovich BC, Russo P, Blute ML, Kattan

MW. Preoperative nomogram to predict positive lymph nodes during nephrectomy for renal cell carcinoma.

- Lucas SM, Yitalo A, Nuss GR, Adibi M, Raman J, Cadeddu JA, Raj GV. The scored value predicts patients with small unilateral renal masses at risk for having or developing chronic kidney disease.

ASCO annual Meeting, Chicago IL (2008)- Nuss GR Lucas SM, Raj GV. The scored value predicts patients

undergoingunilateral nephrectomy for renal masses at risk for having or developing chronic kidney disease

ANNUAL SUO MEETING; UROLOGIC ONCOLOGY. BETHESDA, MD (2008)- Bolenz C, Raj GV, Lotan Y. Utility of biomarkers in predicting outcome of

patients undergoing radical cystectomy.

European Association of Urology Annual Meeting. Stockholm, Sweden (2009)

- Bolenz C, Ortiz N, Ho R, Nuss GR, Raj GV, Sagalowsky AI, Lotan Y. Clinical management of elderly patients with urothelial carcinoma of the bladder at an academic institution: Does it meet current standard of care?

AUA annual meeting. Chicago, IL (2009)- Bolenz C, Ortiz N, Ho R, Nuss GR, Raj GV, Sagalowsky AI, Lotan Y. Clinical

management of elderly patients with urothelial carcinoma of the bladder at an academic institution: Does it meet current standard of care?

- Bolenz C, Shariat SF, Edwards T, Nuss GR, Raj GV, Sagalowsky AI, Lotan Y. Expression of multiple biomarkers is associated with advanced urothelial carcinoma of the bladder in a prospective evaluation.

- Lucas SM, Raman JD, Tracy C, Bagrodia A, Donnally C, Cadeddu JA, and Raj GV. Laparoscopic versus Open Partial Nephrectomy: A Comparison of Renal Function Outcomes in patients with low and high SCORED values.


AUA South Central section annual meeting. Scottsdale AZ (2009)- Bolenz C, Shariat SF, Edwards T, Nuss GR, Raj GV, Sagalowsky AI, Lotan Y.

Expression of multiple biomarkers is associated with advanced urothelial carcinoma of the bladder in a prospective evaluation

- Karavadia SS, Ho R, Arriaga Y, Sagolowsky, A, Lotan Y, Raj GV.Contemporary utilization of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. (Cancer)

ACADEMIC COMMITTEESMember, OR Management Committee (2006- 2009)North Texas VA Medical Center, Dallas TX

Member, OR Throughput Sub-commitee (2007-)Surgical Services Executive CommitteeUT Southwestern Medical Center at Dallas

Medical Student Lecture Series in Urology (2006- )UT Southwestern Medical Center at Dallas

Ambulatory Care Conference to Internal Medicine Residents (2007-UT Southwestern Medical Center at Dallas

Member, Medical Executive Committee (2008- )UT Southwestern Medical Center at Dallas

Member, Referral Tiger Team (2008- )UT Southwestern Medical Center at Dallas

Member, Protocol Review and Monitoring Committee (PRMC) (2008- )UT Southwestern Medical Center at Dallas

CLINICAL ACTIVITIESOrganizer Pelvic Reconstruction/Surgery Consortium UT Southwestern Medical Center at Dallas

RESEARCH MENTORSHIPS

Ankur Anand Rutgers 3rd year undergraduate student (2001-2002)

Utility of prior negative prostate biopsies

James Brashears, BADuke 3rd year medical student lab year (2002-2003)

Animal models of directed renal injury and apoptosis

Ervin Teper, BASUNY Downstate 4th year medical student (2004-5)Predictive utility of urinary cytologies


Rahul IyerDrexel 2nd year undergraduate student (2005-6)Utility of additional prostate tissue resection

Ankur Anand, BADrexel 2nd year medical student (2005-2006)

Comorbidity and renal cell cancer

Zeeshan Dhanawala, BAUT Galveston 2nd year medical student (2007-2008)Post-op nomogram for renal cell cancer

INVITED REVIEWER

Journal of Neurovirology. (1995-7) Ed.: K. Khalili Laboratory Investigation. (1993-7) Ed.: I. Damjanov Dutch Cancer Society. (1999-2003)

Urology (2004- ) Ed.: A. PartinCancer (2006- ) Ed.: R. PollockUrologic Oncology (2006- ) Ed.: M. DrollerAUA Updates (2006 - ) Ed.: G. PremingerJournal of Urology (2007- ) Ed.: M. ResnickBiomed Central Nephrology (2007- ) Ed.: M. NortonIndian Journal of Urology (2007- ) Ed.: N. KekreAdvances in Urology (2008-) Ed.: D. LinNephrology Dialysis and Transplantation (2008 -) Ed: G. Bakris

MEDICAL LICENSURE/BOARD CERTIFICATION

North Carolina State Medical License (2004-2008)New York State Medical License (2004- )Texas State Medical License (2009- )American Board of Urology (2008- )

SOCIETY MEMBERSHIPS

American Urological Association (2000-)Society of Urologic Oncology (2006-)South Central Section of the American Urological Association (2006-)American Society of Clinical Oncology (2007-)Society for Basic Urologic Research (2007- )

EDITORIAL BOARDSSPECIALTY EDITORIAL BOARD,FIVE MINUTE UROLOGY CONSULT (2ND EDITION)Gomella LG, EditorLippincott, Williams and Wilkins, Philadelphia, PA

ADVISORY BOARDBristol Myers Squibb, December 2008

Documents

Ganesh Raj,.doc